Which one affect the other, Recurrent Pregnancy Loss or Serum Level of E?cadherin and c-MycBP
Keywords:Recurrent pregnancy loss (RPL), E-cad, c-MycBP
Recurrent pregnancy loss (RPL) is a foremost life event and a common pregnancy complication, which
defined as losses of two or more pregnancies before 20 weeks of gestation. It affects approximately 1% -
2% of couples trying to have children. To evaluate the potential role of cellular myelocytomatosis binding
protein (c-MycBP) and epithelial cadherin (E-cad) serum level as biomarkers in maternal blood and focus
on the similarity between tumour invasion and embryogenesis as phenomena by c-MycBP and E?cadherin.
This case control study included 50 women with RPL (25 primary RPL and 25 secondary RPL) from three
infertility clinics in Iraq. In addition to 50 control women with no history of RPL and at least one child
birth. Both groups are matched in age and BMI. Blood sampling was done for all and protein level of
c-Myc BP and E-cadherin were measured by ELISA Kit and analysis done according to the manufacturer
recommendations. The result presented in this study showed a significant difference in c?MycBP level
(p<0.001) and E?cadherin (p<0.001) between patients and control. A significant positive correlation has
been found between these two biochemical markers (p <0.001, r=?0.39). The present study showed that
decreasing both c-MycBP and E-cad serum level signpost possible hypothesis that these proteins participate
in one way or another in RPL pathogenesis which affect cell proliferation and invasion. However, this
binding protein transcription factor is a part of a coordinated network of various set of partners which
need further studies in future. Taken together, additional studies are required to understand and clarify the
importance of these biomarkers on this multifactorial condition.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions